Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B
Clinical trial NCT01425723 · COMPLETED
Trial details
- NCT number
- NCT01425723
- Sponsor
- Bioverativ Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-08
- Primary completion
- 2017-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.